Rehabilitating a brain with Alzheimer’s: a proposal

References

• Perez-TurJGenetics and Alzheimer’s diseaseRev Neurol20003016116910730324
   PubMed Web of Science ®Google Scholar
• Lopez de MunainAClassification of mitochondrial diseasesRev Neurol199826Suppl 1S9S149810585
   PubMedGoogle Scholar
• HardyJAllsopDAmyloid deposition as the central event in the aetiology of Alzheimer’s diseaseTrends Pharmacol Sci1991123833881763432
   PubMed Web of Science ®Google Scholar
• JarrettJTLansburyPTJSeeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer’s disease and scrapieCell199373105510588513491
   PubMed Web of Science ®Google Scholar
• HuXHicksCWHeWBACE1 modulates myelination in the central and peripheral nervous systemNat Neurosci200691520152517099708
   PubMed Web of Science ®Google Scholar
• WillemMLammichSHaassCFunction, regulation and therapeutic properties of beta-secretase (BACE1)Semin Cell Dev Biol20092017518219429494
   PubMed Web of Science ®Google Scholar
• NguyenVHawkinsCBergeronCLoss of nicastrin elicits an apoptotic phenotype in mouse embryosBrain Res20061086768416626651
   PubMed Web of Science ®Google Scholar
• GauthierSScheltensPCan we do better in developing new drugs for Alzheimer’s diseaseAlzheimers Dement2009548949119896588
   PubMed Web of Science ®Google Scholar
• QizilbashNBirksJLopez ArrietaJLewingtonSSzetoSWITHDRAWN: Tacrine for Alzheimer’s diseaseCochrane Database Syst Rev2007CD00020217636619
   PubMedGoogle Scholar
• AlfirevicAMillsTCarrDTacrine-induced liver damage: An analysis of 19 candidate genesPharmacogenet Genomics2007171091110018004213
   PubMed Web of Science ®Google Scholar
• TsunoNDonepezil in the treatment of patients with Alzheimer’s diseaseExpert Rev Neurother2009959159819402770
   PubMed Web of Science ®Google Scholar
• WinbladBDonepezil in severe Alzheimer’s diseaseAm J Alzheimers Dis Other Demen20092418519219246572
   PubMed Web of Science ®Google Scholar
• BirksJGrimley EvansJIakovidouVTsolakiMHoltFERivastigmine for Alzheimer’s diseaseCochrane Database Syst Rev2009CD00119119370562
   PubMedGoogle Scholar
• AnnicchiaricoRFedericiAPettenatiCCaltagironeCRivastigmine in Alzheimer’s disease: Cognitive function and quality of lifeTher Clin Risk Manag200731113112318516265
   PubMedGoogle Scholar
• MatharuBGibsonGParsonsRGalantamine inhibits beta-amyloid aggregation and cytotoxicityJ Neurol Sci2009280495819249060
   PubMed Web of Science ®Google Scholar
• MeloJBSousaCGarcaoPOliveiraCRAgostinhoPGalantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neuronsEur J Neurosci20092945546419222556
   PubMed Web of Science ®Google Scholar
• Martinez-CoriaHGreenKNBillingsLMMemantine improves cognition and reduces Alzheimer’s-like neuropathology in transgenic miceAm J Pathol201017687088020042680
   PubMed Web of Science ®Google Scholar
• Aranda-AbreuGEBeharLChungSFurneauxHGinzburgIEmbryonic lethal abnormal vision-like RNA-binding proteins regulate neurite outgrowth and tau expression in PC12 cellsJ Neurosci1999196907691710436048
   PubMed Web of Science ®Google Scholar
• AronovSArandaGBeharLGinzburgIAxonal tau mRNA localization coincides with tau protein in living neuronal cells and depends on axonal targeting signalJ Neurosci2001216577658711517247
   PubMed Web of Science ®Google Scholar
• DubeyMChaudhuryPKabiruHSheaTBTau inhibits anterograde axonal transport and perturbs stability in growing axonal neurites in part by displacing kinesin cargo: Neurofilaments attenuate tau-mediated neurite instabilityCell Motil Cytoskeleton200865899918000878
   PubMed Web of Science ®Google Scholar
• LippensGSillenALandrieuITau aggregation in Alzheimer’s disease: What role for phosphorylationPrion20071212519164903
   PubMed Web of Science ®Google Scholar
• ReltonJKStrijbosPJCooperALRothwellNJDietary N-3 fatty acids inhibit ischaemic and excitotoxic brain damage in the ratBrain Res Bull1993322232268374800
   PubMed Web of Science ®Google Scholar
• FanYYMcMurrayDNLyLHChapkinRSDietary (n-3) polyunsaturated fatty acids remodel mouse T-cell lipid raftsJ Nutr20031331913192012771339
   PubMed Web of Science ®Google Scholar
• BeltzBSTlustyMFBentonJLSandemanDCOmega-3 fatty acids upregulate adult neurogenesisNeurosci Lett200741515415817240063
   PubMed Web of Science ®Google Scholar
• HeringHLinCCShengMLipid rafts in the maintenance of synapses, dendritic spines, and surface AMPA receptor stabilityJ Neurosci2003233262327112716933
   PubMed Web of Science ®Google Scholar
• HouQHuangYAmatoSSnyderSHHuganirRLManHYRegulation of AMPA receptor localization in lipid raftsMol Cell Neurosci20083821322318411055
   PubMed Web of Science ®Google Scholar
• Stetzkowski-MardenFRecouvreurMCamusGCartaudAMarchandSCartaudJRafts are required for acetylcholine receptor clusteringJ Mol Neurosci200630373817192619
   PubMed Web of Science ®Google Scholar
• ClementABGimplGBehlCOxidative stress resistance in hippocampal cells is associated with altered membrane fluidity and enhanced nonamyloidogenic cleavage of endogenous amyloid precursor proteinFree Radic Biol Med2010481236124120156550
   PubMed Web of Science ®Google Scholar
• MaQLYangFRosarioERBeta-amyloid oligomers induce phosphorylation of tau and inactivation of insulin receptor substrate via c-Jun N-terminal kinase signaling: suppression by omega-3 fatty acids and curcuminJ Neurosci2009299078908919605645
   PubMed Web of Science ®Google Scholar
• AmtulZUhrigMRozmahelRFBeyreutherKStructural basis for the differential effects of omega-3 and omega-6 fatty acids on Abeta production and amyloid plaquesJ Biol Chem20101022 [Epub ahead of print]
   Web of Science ®Google Scholar
• WangJWDavidDJMoncktonJEBattagliaFHenRChronic fluoxetine stimulates maturation and synaptic plasticity of adult-born hippocampal granule cellsJ Neurosci2008281374138418256257
   PubMed Web of Science ®Google Scholar
• LucasGDuJRomeasTSelective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the ratPLoS One20105e925320169084
   PubMed Web of Science ®Google Scholar
• KronenbergGCollaMEndresMFolic acid, neurodegenerative and neuropsychiatric diseaseCurr Mol Med2009931532319355913
   PubMed Web of Science ®Google Scholar
• OkenBSStorzbachDMKayeJAThe efficacy of Ginkgo biloba on cognitive function in Alzheimer’s diseaseArch Neurol199855140914159823823
   PubMed Web of Science ®Google Scholar
• BastianettoSZhengWHQuirionRThe Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: Involvement of its flavonoid constituents and protein kinase CJ Neurochem2000742268227710820186
   PubMed Web of Science ®Google Scholar
• GrundmanMGrundmanMDelaneyPAntioxidant strategies for Alzheimer’s diseaseProc Nutr Soc20026119120212133201
   PubMed Web of Science ®Google Scholar
• DrieuKPreparation and definition of Ginkgo biloba extractPresse Med198615145514572947081
   PubMed Web of Science ®Google Scholar
• YaoZDrieuKPapadopoulosVThe Ginkgo biloba extract EGb 761 rescues the PC12 neuronal cells from beta-amyloid-induced cell death by inhibiting the formation of beta-amyloid-derived diffusible neurotoxic ligandsBrain Res200188918119011166702
   PubMed Web of Science ®Google Scholar
• LongpreFGarneauPChristenYRamassamyCProtection by EGb 761 against beta-amyloid-induced neurotoxicity: Involvement of NF-kappaB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formationFree Radic Biol Med2006411781179417157181
   PubMed Web of Science ®Google Scholar
• SovakMGrape extract, resveratrol, and its analogs: A reviewJ Med Food200149310512639418
   PubMedGoogle Scholar
• ConteAPellegriniSTagliazucchiDSynergistic protection of PC12 cells from beta-amyloid toxicity by resveratrol and catechinBrain Res Bull200362293814596889
   PubMed Web of Science ®Google Scholar
• RossiLMazzitelliSArcielloMCapoCRRotilioGBenefits from dietary polyphenols for brain aging and Alzheimer’s diseaseNeurochem Res2008332390240018415677
   PubMed Web of Science ®Google Scholar
• ScaliCProsperiCVannucchiMGPepeuGCasamentiFBrain inflammatory reaction in an animal model of neuronal degeneration and its modulation by an anti-inflammatory drug: Implication in Alzheimer’s diseaseEur J Neurosci2000121900191210886331
   PubMed Web of Science ®Google Scholar
• Candelario-JalilEAlvarezDGonzalez-FalconANeuroprotective efficacy of nimesulide against hippocampal neuronal damage following transient forebrain ischemiaEur J Pharmacol200245318919512398903
   PubMed Web of Science ®Google Scholar
• DaubertEACondronBGSerotonin: A regulator of neuronal morphology and circuitryTrends Neurosci20103342443420561690
   PubMed Web of Science ®Google Scholar
• AltmanHJStoneWSOgrenSOEvidence for a possible functional interaction between serotonergic and cholinergic mechanisms in memory retrievalBehav Neural Biol19874849623632552
   PubMedGoogle Scholar
• BuhotMCMartinSSeguLRole of serotonin in memory impairmentAnn Med20003221022110821328
   PubMed Web of Science ®Google Scholar
• DoughertyJJNicholsRACross-regulation between colocalized nicotinic acetylcholine and 5-HT3 serotonin receptors on presynaptic nerve terminalsActa Pharmacol Sin20093078879419498419
   PubMed Web of Science ®Google Scholar
• National Institutes of HealthAlzheimer′s Disease Medications2008 Available from: http://www.nia.nih.gov/Alzheimers/Publications/medicationsfs.htm. Accessed on January 18, 2010
   Google Scholar
• StixGTurbocharging the brainSci Am2009301464919780452
   PubMed Web of Science ®Google Scholar
• JhaAMAbha. Assessment of cytotoxic and clastogenic effects of nimesulide: An NSAID drug in somatic cells of BALB/c mice in vivoDrug Chem Toxicol20103320420820307146
   PubMed Web of Science ®Google Scholar
• GoncalvesMBWilliamsEJYipPYanez-MunozRJWilliamsGDohertyPThe COX-2 inhibitors, meloxicam and nimesulide, suppress neurogenesis in the adult mouse brainBr J Pharmacol20101591118112520136845
   PubMed Web of Science ®Google Scholar